COMPOUNDS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
申请人:Campbell David
公开号:US20120046283A1
公开(公告)日:2012-02-23
Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of neuropsychiatric conditions.
本文提供了PAK抑制剂及其在治疗神经精神疾病方面的应用方法。
METHODS FOR TREATING ALZHEIMER'S DISEASE
申请人:Lichter Jay
公开号:US20120270844A1
公开(公告)日:2012-10-25
Provided herein arc PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from Alzheimer's disease.
本文提供了PAK抑制剂。同时还提供了治疗患有阿尔茨海默病个体的组合物和方法。
METHODS FOR TREATING SCHIZOPHRENIA
申请人:Lichter Jay
公开号:US20120184547A1
公开(公告)日:2012-07-19
Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from schizophrenia.
提供PAK抑制剂。此外,还提供了用于治疗患有精神分裂症的个体的组合物和方法。
Compounds for treating neuropsychiatric conditions
申请人:Campbell David
公开号:US08674095B2
公开(公告)日:2014-03-18
Provided herein are pyrido[2,3-D]pyrimidin-7(8H)-one compounds and compositions useful as PAK inhibitors. Also provided herein are methods of utilizing these compounds for the treatment of neuropsychiatric conditions. The compounds modulate dendritic spine morphology and/or synaptic function.
Provided herein are PAK inhibitors. Also provided herein are compositions and methods for treating an individual suffering from Mild Cognitive Impairment.